Prospective double-blinded randomized controlled trial of 12-weeks high dose rabeprazole (Pariet) in the treatment of reflux laryngitis in Chinese patients
Phase of Trial: Phase IV
Latest Information Update: 22 Oct 2013
At a glance
- Drugs Rabeprazole (Primary)
- Indications Gastro-oesophageal reflux; Reflux laryngitis
- Focus Therapeutic Use
- 01 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Aug 2007 New trial record.